These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25758209)

  • 1. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
    Beaulieu-Boire I; Fasano A
    Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-induced dyskinesias in Parkinson's disease: what is it all about?
    Barker RA; Kuan WL
    Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
    Maries E; Kordower JH; Chu Y; Collier TJ; Sortwell CE; Olaru E; Shannon K; Steece-Collier K
    Neurobiol Dis; 2006 Jan; 21(1):165-80. PubMed ID: 16095907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience.
    Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A
    Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281
    [No Abstract]   [Full Text] [Related]  

  • 5. Neural transplantation for the treatment of Parkinson's disease.
    Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
    Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereotactic implantation of fetal mesencephalon.
    Hitchcock ER; Kenny BG; Clough CG; Hughes RC; Henderson BT; Detta A
    Stereotact Funct Neurosurg; 1990; 54-55():282-9. PubMed ID: 2080343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskinesias after transplantation in Parkinson's disease.
    Piccini P
    Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular replacement therapy for Parkinson's disease--where we are today?
    Redmond DE
    Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of cell therapies in the treatment of Parkinson's disease.
    Laguna Goya R; Kuan WL; Barker RA
    Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic implantation of foetal mesencephalon (STIM): the UK experience.
    Hitchcock ER; Kenny BG; Clough CG; Hughes RC; Henderson BT; Detta A
    Prog Brain Res; 1990; 82():723-8. PubMed ID: 2290976
    [No Abstract]   [Full Text] [Related]  

  • 11. Grafting of fetal dopamine neurons in Parkinson's disease. The Czech experience with severe akinetic patients.
    Subrt O; Tichy M; Vladyka V; Hurt K
    Acta Neurochir Suppl (Wien); 1991; 52():51-3. PubMed ID: 1792967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical aspects of the use of human fetal brain tissue for intracerebral grafting.
    Brundin P; Björklund A; Lindvall O
    Prog Brain Res; 1990; 82():707-14. PubMed ID: 2290974
    [No Abstract]   [Full Text] [Related]  

  • 14. Trials offer way forward for Parkinson's.
    Abbott A
    Nature; 2001 Mar; 410(6827):401. PubMed ID: 11260676
    [No Abstract]   [Full Text] [Related]  

  • 15. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
    Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
    Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral intracaudate cografting of fetal ventral mesencephalon and striatum in advanced Parkinson's disease.
    Kudoh C; Detta A; Meyer C; Byrne P; Hitchcock E
    Transplant Proc; 1999 Dec; 31(8):3397-402. PubMed ID: 10616520
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
    Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of clinical rating scales and quantitative measurements in assessment pre and post striatal implantation of human foetal mesencephalon in Parkinson's disease.
    Henderson BT; Kenny BG; Hitchcock ER; Hughes RC; Clough CG
    Acta Neurochir Suppl (Wien); 1991; 52():48-50. PubMed ID: 1792966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.
    Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Rehncrona S; Bjorklund A; Lindvall O; Piccini P
    Sci Transl Med; 2010 Jun; 2(38):38ra46. PubMed ID: 20592420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of fetal tissue transplantation for the treatment of advanced Parkinson disease.
    Greene PE; Fahn S
    Neurosurg Focus; 2002 Nov; 13(5):e3. PubMed ID: 15769072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.